Key result
Programmed ventricular stimulation is linked to ~21-fold greater risk of major arrhythmic events in HFmrEF.
Why the study?
Although some post-MI and DCM patients with HFmrEF face an increased risk of arrhythmic SCD, current guidelines do not recommend an ICD.
Does a two-step risk stratification approach using non-invasive risk factors and programmed ventricular stimulation predict major arrhythmic events in hospitalized HFmrEF patients?
Cohort (n=48)
Does a two-step risk stratification approach using non-invasive risk factors and programmed ventricular stimulation predict major arrhythmic events in hospitalized HFmrEF patients?
A two-step risk stratification approach using non-invasive risk factors and programmed ventricular stimulation effectively identifies HFmrEF patients at high risk for major arrhythmic events who may benefit from an ICD.
Answers are grounded in this paper and cite their sources.
May support PVS in HFmrEF risk stratification; leaves open whether it improves ICD selection.
Background Although some post myocardial infarction (post‐MI) and dilated cardiomyopathy (DCM) patients with mid‐range ejection fraction heart failure (HFmrEF/40%‐49%) face an increased risk for arrhythmic sudden cardiac death (SCD), current guidelines do not recommend an implantable cardiac defibrilator (ICD). We risk stratified hospitalized HFmrEF patients for SCD with a combined non‐invasive risk factors (NIRFs) guiding to programmed ventricular stimulation (PVS) two‐step approach. Methods Forty‐eight patients (male = 83%, age = 64 ± 14 years, LVEF = 45 ± 5%, CAD = 69%, DCM = 31%) underwent a NIRFs screening first‐step with electrocardiogram (ECG), SAECG, Echocardiography and 24‐hour ambulatory ECG (AECG). Thirty‐two patients with presence of one of three NIRFs (SAECG ≥ 2 positive criteria for late potentials, ventricular premature beats ≥ 240/24 hours, and non‐sustained ventricular tachycardia [VT] episode ≥ 1/24 hours) were further investigated with PVS. Patients were classified as either low risk (Group 1, n = 16, NIRFs−), moderate risk (Group 2, n = 18, NIRFs+/PVS−), and high risk (Group 3, n = 14, NIRFs+/PVS+). All in Group 3 received an ICD. Results After 41 ± 18 months, 9 of 48 patients, experienced the major arrhythmic event (MAE) endpoint (clinical VT/fibrillation = 3, appropriate ICD activation = 6). The endpoint occurred more frequently in Group 3 (7/14, 50%) than in Groups 1 and 2 (2/34, 5.8%). Logistic regression model adjusted for PVS, age, and LVEF revealed that PVS was an independent MAE predictor (OR: 21.152, 95% CI: 2.618‐170.887, P = .004). Kaplan‐Meier curves diverged significantly (log rank, P < .001) while PVS negative predictive value was 94%. Conclusions In hospitalized HFmrEF post‐MI and DCM patients, a NIRFs guiding to PVS two‐step approach efficiently detected the subgroup at increased risk for MAE.
No takes yet. Share an insight, caveat, or question.
Αρσένος et al. (2020) conducted a cohort in Heart failure with mid-range ejection fraction (HFmrEF) post-MI and DCM (n=48). Non-invasive risk factors (NIRFs) guiding to programmed ventricular stimulation (PVS) two-step approach vs. Low and moderate risk groups (NIRFs- or NIRFs+/PVS-) was evaluated on Major arrhythmic event (MAE) (clinical VT/fibrillation or appropriate ICD activation) (OR 21.152, 95% CI 2.618-170.887, p=0.004). Programmed ventricular stimulation was an independent predictor of major arrhythmic events in HFmrEF patients.
Synapse has enriched 10 related papers. Consider them for comparative context: